Oxaliplatin injection, in combination with infusional fluorouracil and leucovorin, is indicated for: adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor., treatment of advanced colorectal cancer.
From the U.S. FDA-approved label for Oxaliplatin. Full label: DailyMed.
Oxaliplatin injection, in combination with infusional fluorouracil and leucovorin, is indicated for: adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor., treatment of advanced colorectal cancer.
From the U.S. FDA-approved label for Oxaliplatin. Full label: DailyMed.
Administer oxaliplatin injection 85 mg/m 2 as an intravenous infusion over 120 minutes concurrently with leucovorin over 120 minutes in separate bags, followed by fluorouracil on Day 1 of each 14-day cycle. Administer fluorouracil and leucovorin on Day 2 as recommended., Adjuvant Treatment: Continue treatment for up to 12 cycles or unacceptable toxicity., Advanced Colorectal Cancer: Continue treatment until disease progression or unacceptable toxicity.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Oxaliplatin is contraindicated in patients with a history of a hypersensitivity reaction to oxaliplatin or other platinum-based drugs. Reactions have included anaphylaxis., History of hypersensitivity reaction to oxaliplatin or other platinum-based drugs.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Peripheral Sensory Neuropathy: Acute and delayed neuropathy can occur. Avoid topical application of ice. Reduce the dose or permanently discontinue oxaliplatin as recommended., Severe Myelosuppression: Delay oxaliplatin until neutrophils are greater than or equal to 1.5 x 10 9 /L and platelets are greater than or equal to 75 x 10 9 /L. Withhold oxaliplatin for sepsis or septic shock.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following clinically significant adverse reactions are described elsewhere in labeling: Hypersensitivity Reactions, Peripheral Sensory Neuropathy, Severe Myelosuppression, Reversible Posterior Leukoencephalopathy Syndrome, Pulmonary Toxicity, Hepatotoxicity, QT Interval Prolongation and Ventricular Arrhythmias, Rhabdomyolysis, Hemorrhage Most common adverse reactions (incidence greater than or equal to 40%) were…
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
97 products from 52 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| C-Celdach 100mg Injection | Oxaliplatin (100mg) | Celon Lab | |
| C-Celdach 50mg Injection | Oxaliplatin (50mg) | Celon Lab | |
| Oxitan 100mg/ml Injection | Oxaliplatin (100mg/ml) | Fresenius Kabi pharmaceuticals | |
| Oxitan 50mg/ml Injection | Oxaliplatin (50mg/ml) | Fresenius Kabi pharmaceuticals | |
| X-PLAT 100mg/ml Injection | Oxaliplatin (100mg/ml) | Cipla Ltd. | |
| X-PLAT 50mg/ml Injection | Oxaliplatin (50mg/ml) | Cipla Ltd. | |
| Acoxal 50 Injection | Oxaliplatin (50mg) | Accord Pharmaceuticals | vial of 1 Injection |
| Adplatin 100mg Injection | Oxaliplatin (100mg) | Adley Formulations | vial of 50 ml Injection |
| Adplatin 50mg Injection | Oxaliplatin (50mg) | Adley Formulations | vial of 25 ml Injection |
| Celdach 100mg Injection | Oxaliplatin (100mg) | Celon Laboratories Ltd | vial of 1 Injection |
| Celdach 50mg Injection | Oxaliplatin (50mg) | Celon Laboratories Ltd | vial of 1 Injection |
| Coloplate 100mg Injection | Oxaliplatin (100mg) | Cytocare Formulations Pvt Ltd | vial of 1 Injection |
| Coloplate 50mg Injection | Oxaliplatin (50mg) | Cytocare Formulations Pvt Ltd | vial of 1 Injection |
| Dacotin 100 Infusion | Oxaliplatin (100mg) | Dr Reddy's Laboratories Ltd | vial of 1 Infusion |
| Dacotin 50 Injection | Oxaliplatin (50mg) | Dr Reddy's Laboratories Ltd | vial of 1 Injection |
| Dacotin RTU 100 Injection | Oxaliplatin (100mg) | Dr Reddy's Laboratories Ltd | vial of 20 ml Injection |
| Dacotin RTU 50 Injection | Oxaliplatin (50mg) | Dr Reddy's Laboratories Ltd | vial of 1 Injection |
| Eloximed 50mg Injection | Oxaliplatin (50mg) | Aaltramed Healthcare Ltd | vial of 1 Injection |
| Es Oxali 100 Injection | Oxaliplatin (100mg) | Esperer Bioresearch Pvt Ltd | vial of 1 Injection |
| Es Oxali 50 Injection | Oxaliplatin (50mg) | Esperer Bioresearch Pvt Ltd | vial of 1 Injection |
| Fexoplat 100mg Injection | Oxaliplatin (100mg) | Credence Healthcare | vial of 1 Injection |
| Glanoxy 100mg Injection | Oxaliplatin (100mg) | Gland Pharma Limited | vial of 1 Injection |
| Glanoxy 50mg Injection | Oxaliplatin (50mg) | Gland Pharma Limited | vial of 1 Injection |
| Kinaplat 100mg Infusion | Oxaliplatin (100mg) | Cadila Pharmaceuticals Ltd | bottle of 50 ml Infusion |
| Kinaplat 50mg Injection | Oxaliplatin (50mg) | Cadila Pharmaceuticals Ltd | vial of 25 ml Injection |
| Lilxapla 100mg Injection | Oxaliplatin (100mg) | Eli Lilly and Company India Pvt Ltd | vial of 1 Injection |
| Mapsplatin 100mg Injection | Oxaliplatin (100mg) | AMPS Biotech Pvt Ltd | vial of 1 Injection |
| Mapsplatin 50mg Injection | Oxaliplatin (50mg) | AMPS Biotech Pvt Ltd | vial of 1 Injection |
| Megaplat 100mg Injection | Oxaliplatin (100mg) | Alkem Laboratories Ltd | vial of 1 Injection |
| Megaplat 50mg Injection | Oxaliplatin (50mg) | Alkem Laboratories Ltd | vial of 1 Injection |
Showing 30 of 97 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Store at 25°C (77°F); Protect from light (keep in original outer carton).
Storage information from the U.S. FDA-approved label.
Oxaliplatin is recorded in the NepalDoc medicine catalog for: Colorectal cancer, Colon cancer.
For Colorectal cancer: Capecitabine.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.